CSL’s Omnichannel Benchmarking service continues to grow

November 2022

As CSL’s Omnichannel Benchmarking service continues to grow, how does your HCP engagement strategy compare to your competitors?

Shown below is a snapshot of key insights from Q3 2022.

To learn more about how we can help you understand how you are performing compared to your Pharma peers, head to our Omni Benchmarking page. Or alternatively contact us at info@csl-uk.com or call 01483 528302 if you would like to set up a meeting to discuss further. 

Facebook
Twitter
LinkedIn

Featured Article

Economic Factors Squeezing Pharma